[Hyperhomocysteinemia: atherothrombosis and neurotoxicity]
- PMID: 10797837
[Hyperhomocysteinemia: atherothrombosis and neurotoxicity]
Abstract
The positive correlation existing between hyperhomocyst(e)inemia [HH(e)] and vascular disease has firmly been established through data derived from numerous epidemiological and experimental observations. Clinical data corroborate that homocysteine (Hcy) is an independent risk factor for coronary, cerebral and peripheral arterial occlusive disease or peripheral venous thrombosis. Hcy is a sulfhydryl-containing amino acid that is formed by the demethylation of methionine. It is normally catalyzed to cystathionine by cystathionine beta-synthase a pyridoxal phosphate-dependent enzyme. Hcy is also remethylated to methionine by 5-methyltetrahydrofolate-Hcy methyltransferase (methionine synthase), a vitamin B12 dependent enzyme and by betaine-Hcy methyltransferase. Nutritional status such as vitamin B12, or vitamin B6, or folate deficiencies and genetic defects such as cystathionine beta-synthase or methylene-tetrahydrofolate reductase may contribute to increasing plasma homocysteine levels. The pathogenesis of Hcy-induced vascular damage may be multifactorial, including direct Hcy damage to the endothelium, stimulation of proliferation of smooth muscle cells, enhanced low-density lipoprotein peroxidation, increase of platelet aggregation, and effects on the coagulation system. Besides adverse effects on the endothelium and vessel wall, Hcy exert a toxic action on neuronal cells trough the stimulation of N-methyl-D-aspartate (NMDA) receptors. Under these conditions, neuronal damage derives from excessive calcium influx and reactive oxygen generation. This mechanism may contribute to the cognitive changes and markedly increased risk of cerebrovascular disease in children and young adults with homocystunuria. Moreover, during stroke, in hiperhomocysteinemic patients, disruption of the blood-brain barrier results in exposure of the brain to near plasma levels of Hcy. The brain is exposed to 15-50 microM H(e). Thus, the neurotoxicity of Hcy acting through the overstimulation of NMDA receptors could contribute to neuronal damage in homocystinuria and HH(e). Since HH(e) is associated with certain neurodegeneratives diseases, in the present review, the molecular mechanisms involved in neurotoxicity due to Hcy are discussed.
Similar articles
-
[Deregulation of homocysteine metabolism and consequences for the vascular system].Bull Acad Natl Med. 1997 Feb;181(2):313-29; discussion 330-1. Bull Acad Natl Med. 1997. PMID: 9235230 French.
-
Hyperhomocysteinemia: an additional cardiovascular risk factor.WMJ. 1999 Dec;98(8):51-4. WMJ. 1999. PMID: 10639897 Review.
-
The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.J Physiol Pharmacol. 2008 Dec;59 Suppl 9:155-67. J Physiol Pharmacol. 2008. PMID: 19261978 Review.
-
Biochemistry of homocysteine in health and diseases.Indian J Biochem Biophys. 2006 Oct;43(5):275-83. Indian J Biochem Biophys. 2006. PMID: 17133733 Review.
-
Folic acid reduces adhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia.Int J Cardiol. 2006 Jan 13;106(2):285-8. doi: 10.1016/j.ijcard.2005.07.006. Epub 2005 Sep 23. Int J Cardiol. 2006. PMID: 16183151
Cited by
-
Homocysteine inhibits the viability and migration ability of human umbilical vein endothelial cells by downregulating the expression of vascular endothelial growth factor.Exp Ther Med. 2019 Nov;18(5):3913-3919. doi: 10.3892/etm.2019.8043. Epub 2019 Sep 25. Exp Ther Med. 2019. PMID: 31641378 Free PMC article.
-
Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor.Mol Cell Biochem. 2012 Dec;371(1-2):89-96. doi: 10.1007/s11010-012-1425-5. Epub 2012 Aug 12. Mol Cell Biochem. 2012. PMID: 22886392 Free PMC article.
-
Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia.Arch Physiol Biochem. 2006 Oct-Dec;112(4-5):219-27. doi: 10.1080/13813450601093443. Arch Physiol Biochem. 2006. PMID: 17178594 Free PMC article. Review.
-
Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study.Neurol Ther. 2022 Sep;11(3):1353-1374. doi: 10.1007/s40120-022-00380-6. Epub 2022 Jul 2. Neurol Ther. 2022. PMID: 35779189 Free PMC article.
-
Homocysteine and Age-Related Central Nervous System Diseases: Role of Inflammation.Int J Mol Sci. 2021 Jun 10;22(12):6259. doi: 10.3390/ijms22126259. Int J Mol Sci. 2021. PMID: 34200792 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical